A novel serum metabolomic panel distinguishes <scp>I</scp>g<scp>G4</scp>‐related sclerosing cholangitis from primary sclerosing cholangitis
Daniel Radford‐Smith(Warneford Hospital), Fay Probert(University of Oxford), Kate D. Lynch(Royal Adelaide Hospital), Emma Culver(John Radcliffe Hospital), Daniel C. Anthony(University of Oxford), Adam Bailey(University of Oxford), Rory Peters(University of Oxford), Emmanuel Selvaraj(John Radcliffe Hospital), Alessandra Geremia(John Radcliffe Hospital), Michael Pavlides(National Institute for Health and Care Research), Jonathan Bolon(University of Oxford), Michael Orrell(University of Oxford)
Cited by 12
Related Papers
IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
|The Journal of Experimental Medicine|2011|623
Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
|Journal of Hepatology|2013|481
IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies
|Nature Medicine|2021|289
Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases
|Hepatology International|2020|130
Obeticholic acid—a new therapy in PBC and NASH
|British Medical Bulletin|2020|123